Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.
Actinin
/ metabolism
Animals
Cullin Proteins
/ genetics
Disease Models, Animal
Gene Expression Regulation, Developmental
Genetic Predisposition to Disease
/ genetics
Humans
Membrane Proteins
/ metabolism
Mice
Mice, Knockout
/ embryology
Muscle Proteins
/ genetics
Muscle Weakness
/ embryology
Muscle, Skeletal
/ embryology
Muscular Diseases
/ metabolism
Mutation
Myopathies, Nemaline
/ embryology
Neuromuscular Junction
/ growth & development
Ubiquitin-Protein Ligases
/ metabolism
Mouse models
Muscle Biology
Skeletal muscle
Ubiquitin-proteosome system
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
16 04 2019
16 04 2019
Historique:
entrez:
17
4
2019
pubmed:
17
4
2019
medline:
21
7
2020
Statut:
epublish
Résumé
Nemaline myopathy is a congenital neuromuscular disorder characterized by muscle weakness, fiber atrophy and presence of nemaline bodies within myofibers. However, the understanding of underlying pathomechanisms is lacking. Recently, mutations in KBTBD13, KLHL40 and KLHL41, three substrate adaptors for the E3-ubiquitin ligase Cullin-3, have been associated with early-onset nemaline myopathies. We hypothesized that deregulation of Cullin-3 and its muscle protein substrates may be responsible for the disease development. Using Cullin-3 knockout mice, we identified accumulation of non-muscle alpha-Actinins (ACTN1 and ACTN4) in muscles of these mice, which we also observed in KBTBD13 patients. Our data reveal that proper regulation of Cullin-3 activity and ACTN1 levels is essential for normal muscle and neuromuscular junction development. While ACTN1 is naturally downregulated during myogenesis, its overexpression in C2C12 myoblasts triggered defects in fusion, myogenesis and acetylcholine receptor clustering; features that we characterized in Cullin-3 deficient mice. Taken together, our data highlight the importance for Cullin-3 mediated degradation of ACTN1 for muscle development, and indicate a new pathomechanism for the etiology of myopathies seen in Cullin-3 knockout mice and nemaline myopathy patients.
Identifiants
pubmed: 30990797
pii: 125665
doi: 10.1172/jci.insight.125665
pmc: PMC6542616
doi:
pii:
Substances chimiques
ACTN1 protein, human
0
ACTN4 protein, human
0
C2CD2L protein, human
0
Cullin Proteins
0
KBTBD13 protein, human
0
Membrane Proteins
0
Muscle Proteins
0
Actinin
11003-00-2
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL152251
Pays : United States
Organisme : NINDS NIH HHS
ID : P30 NS047101
Pays : United States
Organisme : NIH HHS
ID : S10 OD021724
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128457
Pays : United States
Organisme : NIH HHS
ID : S10 OD016234
Pays : United States
Références
Genes Dev. 1999 Sep 15;13(18):2375-87
pubmed: 10500095
Oncogene. 1999 Nov 18;18(48):6829-34
pubmed: 10597293
J Cell Biol. 2000 Sep 18;150(6):1321-34
pubmed: 10995438
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1595-600
pubmed: 11171996
J Cell Biol. 2001 Apr 16;153(2):329-38
pubmed: 11309414
J Cell Biol. 2001 Apr 16;153(2):413-27
pubmed: 11309420
Science. 2001 Nov 23;294(5547):1704-8
pubmed: 11679633
Neuromuscul Disord. 2003 Aug;13(6):451-5
pubmed: 12899871
J Neurocytol. 2003 Jun-Sep;32(5-8):685-96
pubmed: 15034261
PLoS Biol. 2004 Jun;2(6):e167
pubmed: 15208719
Annu Rev Neurosci. 2004;27:223-46
pubmed: 15217332
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1082-7
pubmed: 15647354
Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20
pubmed: 15688063
Development. 2005 Dec;132(24):5565-75
pubmed: 16280346
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9
pubmed: 16381927
Mol Cell Biol. 2006 Sep;26(17):6522-34
pubmed: 16914736
Dev Dyn. 2007 Apr;236(4):1014-24
pubmed: 17366633
Ann Neurol. 2007 Dec;62(6):597-608
pubmed: 17705262
J Mol Biol. 2008 Feb 15;376(2):338-51
pubmed: 18177667
Cell Div. 2008 Feb 18;3:7
pubmed: 18282298
Neuromuscul Disord. 2008 Jun;18(6):433-42
pubmed: 18482838
Cell Mol Life Sci. 2008 Sep;65(17):2688-701
pubmed: 18488141
PLoS One. 2008 Jun 18;3(6):e2477
pubmed: 18560563
J Microsc. 2008 Sep;231(3):486-93
pubmed: 18755004
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15446-51
pubmed: 18820033
Mol Brain. 2008 Dec 03;1:18
pubmed: 19055765
J Biol Chem. 2009 Mar 20;284(12):8195-206
pubmed: 19158078
Dev Neurobiol. 2009 May;69(6):401-6
pubmed: 19263419
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8935-40
pubmed: 19443691
Genes Cells. 2009 Nov;14(11):1209-25
pubmed: 19849719
J Biol Chem. 2010 Jan 22;285(4):2591-600
pubmed: 19920151
J Cell Biol. 2010 Jan 11;188(1):29-37
pubmed: 20065088
Exp Clin Cardiol. 2009 Fall;14(3):e68-75
pubmed: 20098571
Exp Cell Res. 2010 Apr 15;316(7):1137-47
pubmed: 20156433
Am J Hum Genet. 2010 Dec 10;87(6):842-7
pubmed: 21109227
Biol Cell. 2011 Jun;103(6):287-301
pubmed: 21524273
J Genet. 2011 Aug;90(2):239-49
pubmed: 21869472
Semin Pediatr Neurol. 2011 Dec;18(4):230-8
pubmed: 22172418
Mol Cell Proteomics. 2012 Apr;11(4):M111.010587
pubmed: 22186715
Am J Pathol. 2012 Apr;180(4):1570-80
pubmed: 22349301
Biochem Biophys Res Commun. 2012 May 18;421(4):743-9
pubmed: 22542517
Mol Biol Cell. 2012 Jul;23(13):2490-504
pubmed: 22573887
Intern Emerg Med. 2013 Oct;8(7):553-60
pubmed: 22773188
Dis Model Mech. 2013 Jan;6(1):25-39
pubmed: 23268536
Cell Res. 2013 May;23(5):599-619
pubmed: 23528706
Nature. 2013 May 9;497(7448):263-7
pubmed: 23615608
Am J Hum Genet. 2013 Jul 11;93(1):6-18
pubmed: 23746549
Nature. 2013 Jul 18;499(7458):301-5
pubmed: 23868259
Am J Hum Genet. 2013 Dec 5;93(6):1108-17
pubmed: 24268659
J Biol Chem. 2014 Feb 21;289(8):4969-79
pubmed: 24375477
Biochem J. 2014 Apr 1;459(1):1-13
pubmed: 24627985
Skelet Muscle. 2014 Jun 01;4:11
pubmed: 24959344
J Clin Invest. 2014 Aug;124(8):3529-39
pubmed: 24960163
Dev Biol. 2014 Sep 15;393(2):298-311
pubmed: 25019370
J Electron Microsc Tech. 1989 Jun;12(2):160-71
pubmed: 2503592
Skelet Muscle. 2014 Aug 01;4:15
pubmed: 25110572
Cell. 2014 Dec 4;159(6):1447-60
pubmed: 25433700
J Cancer. 2015 Jan 16;6(3):233-42
pubmed: 25663940
J Biol Chem. 2015 Jun 12;290(24):15350-61
pubmed: 25940086
Physiol Rev. 2015 Jul;95(3):809-52
pubmed: 26109340
J Mol Cell Biol. 2015 Oct;7(5):429-40
pubmed: 26160855
Genetics. 2015 Nov;201(3):1117-31
pubmed: 26384358
Ann Hematol. 2016 Jan;95(1):141-144
pubmed: 26453073
Cell Host Microbe. 2015 Dec 9;18(6):723-35
pubmed: 26651948
J Neurol. 2016 Mar;263(3):517-23
pubmed: 26754003
Biochem J. 2016 Aug 15;473(16):2485-93
pubmed: 27287556
Semin Cell Dev Biol. 2016 Dec;60:121-126
pubmed: 27476112
Neuron. 2016 Dec 7;92(5):1007-1019
pubmed: 27839998
J Mol Biol. 2017 Apr 7;429(7):1045-1066
pubmed: 28238764
Eur J Cell Biol. 2017 Oct;96(7):685-694
pubmed: 28797528
Elife. 2017 Aug 09;6:
pubmed: 28826497
J Clin Invest. 2017 Oct 2;127(10):3730-3740
pubmed: 28872460
Int J Mol Med. 2018 Feb;41(2):1096-1102
pubmed: 29207028
Semin Cell Dev Biol. 2018 Oct;82:51-56
pubmed: 29241690
Cytoskeleton (Hoboken). 2018 May;75(5):213-228
pubmed: 29518289
J Biol Chem. 2018 Jun 8;293(23):8802-8811
pubmed: 29653945
Nature. 1977 Dec 15;270(5638):628-9
pubmed: 563523
Muscle Nerve. 1983 Jan;6(1):69-74
pubmed: 6302503
J Cell Biol. 1983 Jul;97(1):217-23
pubmed: 6408100
J Neurol Sci. 1982 Oct;56(1):35-56
pubmed: 6754876
Exp Cell Res. 1980 Jun;127(2):409-20
pubmed: 6991264
Neuromuscul Disord. 1995 Mar;5(2):93-104
pubmed: 7767098
FEBS Lett. 1997 Sep 29;415(2):163-8
pubmed: 9350988
J Biol Chem. 1997 Nov 7;272(45):28557-62
pubmed: 9353319
EMBO J. 1998 Apr 15;17(8):2208-14
pubmed: 9545234
J Neurosci. 1998 Jun 1;18(11):4166-76
pubmed: 9592096